IVI RMA Research Study Wins Best Paper Prize Award at ASRM 2025 with Juno Genetics
IVI RMA, the world’s leading reproductive medicine group, announced that joint research with Juno Genetics that utilized data from the Foundation for Embryonic Competence and RMA New Jersey won the Best Paper Prize at the American Society for Reproductive Medicine (ASRM) 2025 Annual Scientific Congress & Expo, held in San Antonio, Texas, October 25-29.
PwC Strategy& Releases Report at IVI RMA Congress Showing Potential of Assisted Reproductive Technology to Mitigate Economic Impact of Demographic Changes in the U.S.
At the 11th International IVI RMA Congress, hosted by IVI RMA, the world’s leading reproductive medicine group with 200+ Assisted Reproductive Technology (ART) clinics in 15 countries and 22 labs across North America, PwC Strategy& released a report that analyzes the impact of aging populations and sustained low birth rates on economic and social dynamics in the United States and other countries. With fertility rates well below replacement levels and the average age of first-time parents rising, the report, “Shaping the Future: Socioeconomic Challenges and Opportunities in Aging Societies,” points to fertility medicine as a key lever for supporting social and economic sustainability.
IVI RMA Completes Acquisition of North American Operations of Eugin Group, Including Boston IVF and TRIO
IVI RMA, one of the largest reproductive medicine groups in the world, today announced that it has completed the acquisition of North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO. The strategic additions further IVI RMA market leadership in North America and reinforce the company’s commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.
IVI RMA To Acquire North American Operations of Eugin Group, Including Boston IVF, Creating a Leading North American Fertility Group
IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company’s commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.
Lynn Mason Appointed Chief Executive Officer for IVI RMA America
IVI RMA America, the North American business of IVI RMA, the largest reproductive medicine group in the world, today announced the appointment of Lynn Mason as Chief Executive Officer. She will oversee the North American operations as well as growth initiatives in support of bringing better fertility outcomes to more patients across the United States and Canada.
